Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery
Sponsor: Abbott Diabetes Care
This NA trial investigates Critical Illness and is currently completed. Abbott Diabetes Care leads this study, which shows 11 recorded versions since 2008 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Mar 2018 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Jun 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Diabetes Care
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .